These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2759242

  • 21. [The ADP-ribosylation site and RNA-binding center are located in different regions of the elongation factor EF-2].
    Davydova EK.
    Dokl Akad Nauk SSSR; 1986; 289(2):510-2. PubMed ID: 2427294
    [No Abstract] [Full Text] [Related]

  • 22. [Structure-activity domain of elongation factor EF-2. Analysis of fragments of limited EF-2 hydrolysis, obtained using trypsin and elastase].
    Motuz LP, Plotnikov AN, Korotkov KV, Alakhov IuB.
    Bioorg Khim; 1994; 20(8-9):872-82. PubMed ID: 7826414
    [Abstract] [Full Text] [Related]

  • 23. Introduction of additional charges as an aid in protein purification: isolation of elongation factor 2 from Sulfolobus acidocaldarius by preparative isoelectric focusing before and after ADP-ribosylation.
    Siegmund KD, Klink F.
    Protein Expr Purif; 1994 Dec; 5(6):553-8. PubMed ID: 7858424
    [Abstract] [Full Text] [Related]

  • 24. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M, Nurten R, Ergen K, Bermek E.
    Cell Biochem Funct; 2006 Dec; 24(4):369-80. PubMed ID: 16142694
    [Abstract] [Full Text] [Related]

  • 25. Purification and properties of an altered form of elongation factor 2 from mutant cells resistant to intoxication by diphtheria toxin.
    Iglewski WJ, Lee H.
    Eur J Biochem; 1983 Aug 01; 134(2):237-40. PubMed ID: 6307688
    [Abstract] [Full Text] [Related]

  • 26. Increased phosphorylation of elongation factor 2 in Alzheimer's disease.
    Johnson G, Gotlib J, Haroutunian V, Bierer L, Nairn AC, Merril C, Wallace W.
    Brain Res Mol Brain Res; 1992 Oct 01; 15(3-4):319-26. PubMed ID: 1331687
    [Abstract] [Full Text] [Related]

  • 27. [The eukaryotic elongation factor EF-2 loses its nonspecific affinity for RNA as a result of ADP ribosylation].
    Bezlepkina TA, Davydova EK, Sitikov AS, Vertiev IuA, Ezepchuk IuV.
    Dokl Akad Nauk SSSR; 1984 Oct 01; 278(3):751-4. PubMed ID: 6209075
    [No Abstract] [Full Text] [Related]

  • 28. Heterogeneity of native rat liver elongation factor 2.
    Marzouki A, Lavergne JP, Reboud JP, Reboud AM.
    FEBS Lett; 1989 Sep 11; 255(1):72-6. PubMed ID: 2792373
    [Abstract] [Full Text] [Related]

  • 29. Gene for the diphtheria toxin-susceptible elongation factor 2 from Methanococcus vannielii.
    Lechner K, Heller G, Böck A.
    Nucleic Acids Res; 1988 Aug 25; 16(16):7817-26. PubMed ID: 3419900
    [Abstract] [Full Text] [Related]

  • 30. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K, Bektaş M, Gökçe S, Nurten R.
    Biocell; 2007 Aug 25; 31(1):61-6. PubMed ID: 17665640
    [Abstract] [Full Text] [Related]

  • 31. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
    Blanke SR, Huang K, Wilson BA, Papini E, Covacci A, Collier RJ.
    Biochemistry; 1994 May 03; 33(17):5155-61. PubMed ID: 8172890
    [Abstract] [Full Text] [Related]

  • 32. Molecular, functional and structural properties of an archaebacterial elongation factor 2.
    Raimo G, Masullo M, Parente A, Dello Russo A, Bocchini V.
    Biochim Biophys Acta; 1992 Sep 24; 1132(2):127-32. PubMed ID: 1390884
    [Abstract] [Full Text] [Related]

  • 33. Endogenous ADP-ribosylation of elongation factor 2 in polyoma virus-transformed baby hamster kidney cells.
    Fendrick JL, Iglewski WJ.
    Proc Natl Acad Sci U S A; 1989 Jan 24; 86(2):554-7. PubMed ID: 2536169
    [Abstract] [Full Text] [Related]

  • 34. Characterization of Ca2+/calmodulin-dependent protein kinase in rat pancreatic islets.
    Hughes SJ, Smith H, Ashcroft SJ.
    Biochem J; 1993 Feb 01; 289 ( Pt 3)(Pt 3):795-800. PubMed ID: 8382051
    [Abstract] [Full Text] [Related]

  • 35. Reduced levels of ADP-ribosylatable elongation factor-2 in aged and SV40-transformed human cell cultures.
    Riis B, Rattan SI, Derventzi A, Clark BF.
    FEBS Lett; 1990 Jun 18; 266(1-2):45-7. PubMed ID: 2163888
    [Abstract] [Full Text] [Related]

  • 36. Endogenous ADP-ribosylation of elongation factor 2 in polyribosome fraction of rabbit reticulocytes.
    Sitikov AS, Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1984 Oct 15; 176(1):261-3. PubMed ID: 6092136
    [Abstract] [Full Text] [Related]

  • 37. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1990 Feb 26; 261(2):350-2. PubMed ID: 2311763
    [Abstract] [Full Text] [Related]

  • 38. Posttranslational modification of elongation factor 2 in diphtheria-toxin-resistant mutants of CHO-K1 cells.
    Moehring JM, Moehring TJ, Danley DE.
    Proc Natl Acad Sci U S A; 1980 Feb 26; 77(2):1010-4. PubMed ID: 6928655
    [Abstract] [Full Text] [Related]

  • 39. Role of calmodulin-dependent phosphorylation of elongation factor 2 in the proliferation of rat glial cells.
    Bagaglio DM, Hait WN.
    Cell Growth Differ; 1994 Dec 26; 5(12):1403-8. PubMed ID: 7696190
    [Abstract] [Full Text] [Related]

  • 40. Structure-activity relationships in diphtheria toxin and exotoxin A from Pseudomonas aeruginosa.
    Collier RJ, Gilliland DG, Lory S.
    Prog Clin Biol Res; 1979 Dec 26; 31():751-9. PubMed ID: 119972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.